NHC

NATIONAL HEALTHCARE CORP
10 filings tracked
healthcarehealthcare facilities managementSMALL ($300M-2B)

Signal Magnitude Chart

BULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureBULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureBULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureBULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureBULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureBULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureBULLISH | 80% | 5/7/2026 | earnings beatBULLISH | 60% | 5/7/2026 | margin expansionBULLISH | 90% | 5/7/2026 | acquisitionBULLISH | 70% | 5/7/2026 | debt restructureNEUTRAL | 20% | 5/13/2026 | management changeNEUTRAL | 10% | 5/13/2026 | dividend changeNEUTRAL | 20% | 5/13/2026 | management changeNEUTRAL | 10% | 5/13/2026 | dividend changeNEUTRAL | 90% | 5/27/2026 | capital raiseBULLISH | 70% | 5/27/2026 | acquisitionNEUTRAL | 50% | 5/27/2026 | debt restructureMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

neutralMay 27

Secured $525 million in new credit facilities to fund an asset acquisition.

capital raise
90%
bullishMay 27

Strategic move to acquire assets and real property from National Health Investors.

acquisition
70%
neutralMay 27

Replacing existing credit facility with a larger, structured term loan and revolver.

debt restructure
50%
neutralMay 13

Re-election of board directors confirms continuity in leadership.

management change
20%
neutralMay 13

Executive compensation approved by shareholders.

dividend change
10%
neutralMay 13

Re-election of board directors confirms continuity in leadership.

management change
20%
neutralMay 13

Executive compensation approved by shareholders.

dividend change
10%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%
bullishMay 7

Adjusted net income surged 21.1% year-over-year to $30.1 million.

earnings beat
80%
bullishMay 7

Operating margins improved to 8.4% driven by a 28% reduction in agency staffing costs.

margin expansion
60%
bullishMay 7

Agreement to acquire $560 million in real estate assets from NHI.

acquisition
90%
bullishMay 7

Aggressive deleveraging with $40 million in principal repayments during the quarter.

debt restructure
70%

Filing History

8-KMay 27, 2026

The filing details a pivotal shift in NHC's capital structure, moving from a lean balance sheet to a leveraged growth posture to facilitate a major asset acquisition. While the acquisition of real property from National Health Investors offers a clear path to increased stability and scale, it ties the company's financial health to the successful closing of the deal and the maintenance of strict leverage ratios. Investors must now weigh the potential for accretive growth against the increased risk of debt service in a fluctuating interest rate environment.

8-KMay 13, 2026

The 8-K filing confirms the successful completion of National HealthCare Corporation's annual meeting, resulting in the re-election of the board and approval of executive pay. While the headline results suggest a unified front, the underlying vote distribution reveals a small but present level of shareholder dissatisfaction. Ultimately, the company maintains a stable leadership structure, but investors will likely monitor whether this dissent grows into a broader challenge to management's capital allocation strategy.

10-QMay 7, 2026

The Q1 2026 filing presents a company at a critical crossroads, balancing impressive short-term operational gains against long-term structural risks. On one hand, the acceleration in operating cash flow and the aggressive pay-down of $40 million in long-term debt signal a management team focused on financial agility and deleveraging. The pending $560 million real estate acquisition represents a bold bet on vertical integration that could fundamentally change the company's risk profile and asset base. However, the synthesis of the data suggests that the 'win' is not yet absolute. The reliance on non-operating gains and the persistent threat of labor cost escalation create a narrow path to sustained margin expansion. Investors must weigh the ability of NHC to execute its asset acquisition strategy against the backdrop of a restrictive regulatory environment and a concentrated investment portfolio. The ultimate trajectory will likely depend on whether the shift to asset ownership can offset the inherent volatility of the senior healthcare reimbursement model.